- BIST10011,430-2.49%
- USD49.45+0.05%
- EUR55.62+0.37%
- GOLD4,163.20-0.43%
- INTEREST37.00%-1.00
- BITCOIN81,872-0.17%
- October 19, 202616°
- BIST10011,430-2.49%
- USD49.45+0.05%
- EUR55.62+0.37%
- GOLD4,163.20-0.43%
- INTEREST37.00%-1.00
- BITCOIN81,872-0.17%
- October 19, 202616°
Australia decides to continue use of controversial herbicide paraquat
Australia announced it will continue allowing the use of the herbicide paraquat, which is banned in over 70 countries due to a potential link to Parkinson's disease, but will tighten application conditions.
The Australian Pesticides and Veterinary Medicines Authority (APVMA) has completed a long-running review of paraquat and a similar chemical, diquat, used in agriculture in the country. The authority announced that the use of both substances will continue, but application conditions will be tightened to reduce risks to wildlife and the environment.
Decision based on scientific research
APVMA Chief Scott Hansen stated that the decision was based on the analysis of hundreds of scientific studies and long-term data. Hansen said that although there is no proven causal link between paraquat use and Parkinson's disease, additional precautions have been taken due to potential effects on users and animals.
Farmers and scientists hold opposing views
According to ABC News, scientists and organizations studying Parkinson's disease criticized this decision. On the other hand, farmers oppose a complete ban on the chemical, arguing it plays a critical role in weed control for growing grains, cotton, sugarcane, and horticultural products.
Banned in over 70 countries
Paraquat, which is at the center of debates over its high toxicity and potential link to Parkinson's disease, is banned in over 70 countries, including European Union nations, the United Kingdom, and China. Australia's decision allows for the controlled use of the chemical despite these bans.
Stay Updated with RuskiGazeta
Subscribe to be informed about special news, developments and announcements. We will keep you informed.
By signing up, you agree to our Privacy Policy
